Bayer partners with Impli
Bayer has forged a partnership with Impli, a deep-tech start-up in precision care. Impli’s goal is to advance women’s health and deliver the first real-time hormone monitoring device – making fertility more accessible, safer and more successful.
With hormones playing a critical role in many of our body’s systems and functions, real-time monitoring can help unlock key insights necessary to make smarter, more precise decisions about a person’s health care, Bayer said.
Terms of the partnership were not disclosed, but it is intended to advance early-stage research while exploring a variety of potential use cases for hormone monitoring and providing Impli with access to Bayer’s global innovation ecosystem. The partnership is the result of Impli winning a Bayer-sponsored innovation challenge at the HLTH Europe conference earlier this year.
[Read more: Bayer unveils healthy-aging ecosystem for consumers]
“New technologies are helping us answer one of the largest consumer unmet needs: better understanding what is happening in their own body and what it means for managing their health journey,” said Aquil Harjivan, head of front-end innovation for the consumer health division of Bayer. “We are excited to join cutting-edge innovators like Impli to explore the exciting frontiers of making health care more precise for every individual.”
“Reimagining women's hormonal health is more than a challenge; it's an opportunity to innovate and transform lives. The opportunity to break barriers together with a pioneering leader in the field such as Bayer is not just exciting—it's a chance to create meaningful change and deliver better outcomes for everyone,” said Anna Luisa Schaffgotsch CEO, Impli.
Bayer noted that it sees potential for advancements across its self-care categories with deeper understanding of a person’s hormones and their potential impact on conditions like stress, sleep, weight management, cardiovascular health, women’s health or bone health.
Bayer said that since launching a new business unit focused on Precision Health, it has emerged as an industry leader in partnering with innovative companies bringing new digital tools to consumers. Earlier this year in the United States, Bayer launched the One-a-Day Age Factor ecosystem to help consumers better understand and manage their personal aging journey at the cellular level.
[Related: Body, heal thyself]
“Each of us are on a unique health journey,” Harjivan added. “Better insights and diagnostics coupled with trusted self-care products pave the way for us all to better manage our own journeys.”